Income Taxes (Details) - USD ($) $ in Millions |
3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2015 |
Jun. 30, 2014 |
Jun. 30, 2015 |
Jun. 30, 2014 |
|
Effective tax rate (as a percent) | 19.00% | 23.00% | 22.00% | 24.00% |
Statutory tax rate (as a percent) | 35.00% | |||
Reasonably possible amount that gross unrecognized tax benefits may change within the next twelve months, high end of range | $ 22 | $ 22 | ||
Pharmacyclics Inc | State | ||||
Valuation allowances | $ 103 | $ 103 |
X | ||||||||||
- Definition Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition Percentage of domestic federal statutory tax rate applicable to pretax income (loss). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition Amount of (increase) decrease reasonably possible in the estimated upper bound of the unrecognized tax benefit for a tax position taken or expected to be taken. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|